| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679233 | Seminars in Vascular Surgery | 2017 | 5 Pages |
Abstract
Patients with connective tissue disorder present a particular clinical challenge in the treatment of aortic graft infections. Specific complexities arise in patients with connective tissue disorders when reoperation for aortic graft infection is required. Herein we describe current management of infected aortic grafts in patients with connective tissue disorders using homograft and rifampin-coated graft replacements using in situ replacement therapy, which is associated with improved outcome compared to graft excision and extra-anatomic bypass.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Natalia O. Glebova, James H. III,